Elucidating the Underlying Functional Mechanisms of Breast Cancer Susceptibility Through Post-GWAS Analyses

por Rivandi, Mahdi, Martens, John W. M., Hollestelle, Antoinette
Publicado en Front Genet (2018)

A novel independence test for somatic alterations in cancer shows that biology drives mutual exclusivity but chance explains most co-occurrence

por Canisius, Sander, Martens, John W. M., Wessels, Lodewyk F. A.
Publicado en Genome Biol (2016)

Stromal cells promote anti-estrogen resistance of breast cancer cells through an insulin-like growth factor binding protein 5 (IGFBP5)/B-cell leukemia/lymphoma 3 (Bcl-3) axis

por Leyh, Benjamin, Dittmer, Angela, Lange, Theresia, Martens, John W. M., Dittmer, Jürgen
Publicado en Oncotarget (2015)

Association between Acquired Uniparental Disomy and Homozygous Mutations and HER2/ER/PR Status in Breast Cancer

por Tuna, Musaffe, Smid, Marcel, Zhu, Dakai, Martens, John W. M., Amos, Christopher I.
Publicado 2010

Mitochondrial RNA Expression and Single Nucleotide Variants in Association with Clinical Parameters in Primary Breast Cancers

por Weerts, Marjolein J. A., Smid, Marcel, Foekens, John A., Sleijfer, Stefan, Martens, John W. M.
Publicado en Cancers (Basel) (2018)

Genomic profiling of CHEK2*1100delC-mutated breast carcinomas

por Massink, Maarten P. G., Kooi, Irsan E., Martens, John W. M., Waisfisz, Quinten, Meijers-Heijboer, Hanne
Publicado en BMC Cancer (2015)

A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients

por Jongbloed, Elisabeth M., Deger, Teoman, Sleijfer, Stefan, Martens, John W. M., Jager, Agnes, Wilting, Saskia M.
Publicado en Cancers (Basel) (2021)

Insecticidal Activity of a Bacterial Crystal Protein Expressed by a Recombinant Baculovirus in Insect Cells

por Martens, John W. M., Honée, Guy, Zuidema, Douwe, van Lent, Jan W. M., Visser, Bert, Vlak, Just M.
Publicado 1990

Co-regulated gene expression of splicing factors as drivers of cancer progression

por Koedoot, Esmee, Smid, Marcel, Foekens, John A., Martens, John W. M., Le Dévédec, Sylvia E., van de Water, Bob
Publicado en Sci Rep (2019)

Novel methods to diagnose leptomeningeal metastases in breast cancer

por Angus, Lindsay, Martens, John W M, van den Bent, Martin J, Sillevis Smitt, Peter A E, Sleijfer, Stefan, Jager, Agnes
Publicado en Neuro Oncol (2019)

Proteomics Pipeline for Biomarker Discovery of Laser Capture Microdissected Breast Cancer Tissue

por Liu, Ning Qing, Braakman, René B. H., Stingl, Christoph, Luider, Theo M., Martens, John W. M., Foekens, John A., Umar, Arzu
Publicado 2012

Mitochondrial DNA content in breast cancer: Impact on in vitro and in vivo phenotype and patient prognosis

por Weerts, Marjolein J.A., Sieuwerts, Anieta M., Smid, Marcel, Look, Maxime P., Foekens, John A., Sleijfer, Stefan, Martens, John W.M.
Publicado en Oncotarget (2016)

Increased MAPK1/3 Phosphorylation in Luminal Breast Cancer Related with PIK3CA Hotspot Mutations and Prognosis

por Ramirez-Ardila, Diana, Timmermans, A. Mieke, Helmijr, Jean A., Martens, John W.M., Berns, Els M.J.J., Jansen, Maurice P.H.M.
Publicado en Transl Oncol (2017)

Cancer-associated fibroblast-derived Gremlin 1 promotes breast cancer progression

por Ren, Jiang, Smid, Marcel, Iaria, Josephine, Salvatori, Daniela C. F., van Dam, Hans, Zhu, Hong Jian, Martens, John W. M., ten Dijke, Peter
Publicado en Breast Cancer Res (2019)

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen

por M. Sieuwerts, Anieta, A. Inda, Márcia, Smid, Marcel, van Ooijen, Henk, van de Stolpe, Anja, Martens, John W. M., Verhaegh, Wim F. J.
Publicado en Cancers (Basel) (2020)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?

por van Barele, Mark, Heemskerk-Gerritsen, Bernadette A. M., Louwers, Yvonne V., Vastbinder, Mijntje B., Martens, John W. M., Hooning, Maartje J., Jager, Agnes
Publicado en Cancers (Basel) (2021)

An increased cell cycle gene network determines MEK and Akt inhibitor double resistance in triple-negative breast cancer

por van der Noord, Vera E., McLaughlin, Ronan P., Smid, Marcel, Foekens, John A., Martens, John W. M., Zhang, Yinghui, van de Water, Bob
Publicado en Sci Rep (2019)

Multi-targeted kinase inhibition alleviates mTOR inhibitor resistance in triple-negative breast cancer

por He, Jichao, McLaughlin, Ronan P., van der Noord, Vera, Foekens, John A., Martens, John W. M., van Westen, Gerard, Zhang, Yinghui, van de Water, Bob
Publicado en Breast Cancer Res Treat (2019)

Defining the dimensions of circulating tumor cells in a large series of breast, prostate, colon, and bladder cancer patients

por Mendelaar, Pauline A. J., Kraan, Jaco, Van, Mai, Zeune, Leonie L., Terstappen, Leon W. M. M., Oomen‐de Hoop, Esther, Martens, John W. M., Sleijfer, Stefan
Publicado en Mol Oncol (2020)

Splicing factors control triple-negative breast cancer cell mitosis through SUN2 interaction and sororin intron retention

por Koedoot, Esmee, van Steijn, Eline, Vermeer, Marjolein, González-Prieto, Román, Vertegaal, Alfred C. O., Martens, John W. M., Le Dévédec, Sylvia E., van de Water, Bob
Publicado en J Exp Clin Cancer Res (2021)